4//SEC Filing
Palleiko Benjamin L 4
Accession 0001415889-25-022965
CIK 0001348911other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 7:46 PM ET
Size
9.5 KB
Accession
0001415889-25-022965
Insider Transaction Report
Form 4
Palleiko Benjamin L
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Sale
Common Stock
2025-08-22$13.22/sh−10,940$144,657→ 386,858 total - Exercise/Conversion
Restricted Stock Unit
2025-08-21−23,250→ 325,500 total→ Common Stock (23,250 underlying) - Exercise/Conversion
Common Stock
2025-08-21+23,250→ 397,798 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 21, 2025, subject to continued service through each vesting date.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001366244
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 7:46 PM ET
- Size
- 9.5 KB